Edition:
India

Argos Therapeutics Inc (ARGS.OQ)

ARGS.OQ on NASDAQ Stock Exchange Global Market

0.16USD
11 Dec 2017
Change (% chg)

$-0.01 (-3.31%)
Prev Close
$0.16
Open
$0.17
Day's High
$0.17
Day's Low
$0.15
Volume
397,880
Avg. Vol
882,137
52-wk High
$5.65
52-wk Low
$0.13

Latest Key Developments (Source: Significant Developments)

Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Argos Therapeutics Inc ::ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING.ARGOS THERAPEUTICS-UNDER AGREEMENT,CO AGREED TO MAKE, ISSUE & DELIVER TO SAINT-GOBAIN, AN UNSECURED CONVERTIBLE PROMISSORY NOTE IN AMOUNT OF $2.4 MLN‍​.ARGOS - ‍IN CONNECTION WITH DEAL, CO, SAINT-GOBAIN ENTERED INTO AMENDMENT TO DEVELOPMENT DEAL TO EXTEND TERM OF DEVELOPMENT DEAL TO DEC 31, 2019​.ARGOS THERAPEUTICS- UNDER AGREEMENT,CO AGREED TO MAKE, ISSUE & DELIVER TO SAINT-GOBAIN,CASH PAYMENT OF $500,000, 689,995 SHARES OF CO'S COMMON STOCK.  Full Article

Argos Provides Financial Update
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Argos Therapeutics Inc ::ARGOS PROVIDES FINANCIAL UPDATE.ARGOS THERAPEUTICS - ‍TKC PROPERTIES HAS, WITH ARGOS' FULL CONSENT, SUCCESSFULLY COMPLETED SALE OF FACILITY IN DURHAM COUNTY, NC TO A THIRD PARTY​.ARGOS THERAPEUTICS-RAISED ABOUT $6.8 MILLION NET PROCEEDS UNDER ITS AT-THE-MARKET STOCK ISSUANCE FACILITY WITH COWEN & CO SUBSEQUENT TO Q3 CLOSE ON SEPT 30​.ARGOS THERAPEUTICS - ‍IN CONNECTION WITH DEAL, CO ENTERED LEASE TERMINATION DEAL WITH TKC, TO WHICH CO RECEIVED CASH PROCEEDS OF ABOUT $1.8 MILLION​.ARGOS THERAPEUTICS INC - ‍COMPANY BELIEVES IT NOW HAS SUFFICIENT CASH TO EXECUTE ITS BUSINESS PLAN AT LEAST THROUGH JUNE 2018​.  Full Article

Argos reports third quarter financial results
Friday, 10 Nov 2017 

Nov 9 (Reuters) - Argos Therapeutics Inc :Argos reports third quarter 2017 financial results and operational highlights.Qtrly loss per share $0.10 ‍​.  Full Article

Argos Therapeutics files for offering of 13.5 mln shares of common stock by Invetech
Saturday, 4 Nov 2017 

Nov 3 (Reuters) - Argos Therapeutics Inc :Argos Therapeutics files for offering of 13.5 million shares of common stock by Invetech Pty Ltd - SEC filing.  Full Article

BRIEF-Pharmstandard International reports open market purchase of 53,524 shares of Argos Therapeutics at avg price of $4.23/shr
Wednesday, 24 Aug 2016 

Corrects headline to say Pharmstandard International purchased shares of Argos Therapeutics.Argos Therapeutics Inc : Pharmstandard International SA reports open market purchase of 53,524 shares of co's common stock at average price of $4.23 per share on Aug. 19 .Pharmstandard International SA reports purchase of 21,950 shares of co's common stock at average price of $4.26 per share on Aug. 22.  Full Article

Argos Therapeutics Q2 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S
Thursday, 11 Aug 2016 

Argos Therapeutics Inc : Argos Therapeutics reports second quarter 2016 financial results and recent operational highlights . Q2 revenue $500,000 versus $100,000 . Q2 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S . Q2 loss per share $0.48 .Q2 revenue view $196,000 -- Thomson Reuters I/B/E/S.  Full Article

Argos Therapeutics announces proposed public offering of common stock and warrants
Thursday, 28 Jul 2016 

Argos Therapeutics Inc :Argos Therapeutics announces proposed public offering of common stock and warrants.  Full Article

Argos Therapeutics files for common stock offering
Saturday, 23 Jul 2016 

Argos Therapeutics Inc :Files for common stock offering of up to 19.5 mln shares by the selling shareholders - SEC filing.  Full Article

Argos Therapeutics appoints Richard D. Katz as Chief Financial Officer
Monday, 11 Jul 2016 

Argos Therapeutics Inc : Dr. Richard D. Katz joins Argos Therapeutics as Chief Financial Officer . Most recently, Katz served as Chief Financial Officer for Viamet Pharmaceuticals, Inc. .Compensation committee of co's board approved inducement grant of option to purchase 300,000 shares of co's common stock to Katz.  Full Article

Argos Therapeutics files for resale of up to 6.4 mln shares
Saturday, 14 May 2016 

Argos Therapeutics Inc :Files for resale of up to 6.4 million shares of common stock - sec filing.  Full Article

BRIEF-Argos Therapeutics Enters Into Agreement With Saint-Gobain Performance Plastics Corp

* ARGOS THERAPEUTICS - ‍ON NOV 22, ENTERED INTO A SATISFACTION AND RELEASE AGREEMENT WITH SAINT-GOBAIN PERFORMANCE PLASTICS CORP - SEC FILING